Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcessventricular cardiac muscle cell action potential

DSG2 DSP KCNE5 RYR2 NOS1

6.65e-06371495GO:0086005
DomainDUF1220

NBPF15 NBPF9 NBPF14

7.83e-05111493PF06758
DomainNBPF_dom

NBPF15 NBPF9 NBPF14

7.83e-05111493IPR010630
DomainNBPF

NBPF15 NBPF9 NBPF14

7.83e-05111493PS51316
DomainRyanodine_rcpt

RYR1 RYR2

1.89e-0431492IPR003032
DomainRyanrecept_TM4-6

RYR1 RYR2

1.89e-0431492IPR009460
DomainRyR

RYR1 RYR2

1.89e-0431492PF02026
DomainRR_TM4-6

RYR1 RYR2

1.89e-0431492PF06459
DomainRyan_recept

RYR1 RYR2

1.89e-0431492IPR013333
DomainRNaseH-like_dom

SETMAR FAM200B GTF2IRD2B GTF2IRD2 THAP12

2.25e-04691495IPR012337
Domain-

GTF2IRD2B GTF2IRD2

3.75e-04414923.90.1460.10
DomainSPHK1-interactor_AKAP_110

SPHKAP AKAP11

3.75e-0441492IPR008382
DomainGTF2I

GTF2IRD2B GTF2IRD2

3.75e-0441492PS51139
DomainGTF2I

GTF2IRD2B GTF2IRD2

3.75e-0441492PF02946
DomainAKAP_110

SPHKAP AKAP11

3.75e-0441492PF05716
DomainGTF2I

GTF2IRD2B GTF2IRD2

3.75e-0441492IPR004212
DomainDnaJ

GAK DNAJC18 DNAJC6 DNAJC5B

5.76e-04481494PF00226
DomainBCDHK_Adom3

PDK1 PDK4

6.22e-0451492PF10436
DomainHis_kinase_dom

PDK1 PDK4

6.22e-0451492IPR005467
DomainHIS_KIN

PDK1 PDK4

6.22e-0451492PS50109
DomainBCDHK/PDK_N

PDK1 PDK4

6.22e-0451492IPR018955
Domain-

PDK1 PDK4

6.22e-04514921.20.140.20
DomainDNAJ_1

GAK DNAJC18 DNAJC6 DNAJC5B

6.24e-04491494PS00636
DomainDNAJ_2

GAK DNAJC18 DNAJC6 DNAJC5B

6.24e-04491494PS50076
DomainDnaJ

GAK DNAJC18 DNAJC6 DNAJC5B

6.24e-04491494SM00271
Domain-

GAK DNAJC18 DNAJC6 DNAJC5B

6.24e-044914941.10.287.110
DomainDnaJ_domain

GAK DNAJC18 DNAJC6 DNAJC5B

7.27e-04511494IPR001623
DomainRIH_assoc-dom

RYR1 RYR2

9.29e-0461492IPR013662
DomainIns145_P3_rec

RYR1 RYR2

9.29e-0461492PF08709
DomainRIH_assoc

RYR1 RYR2

9.29e-0461492PF08454
DomainRIH_dom

RYR1 RYR2

9.29e-0461492IPR000699
DomainIns145_P3_rcpt

RYR1 RYR2

9.29e-0461492IPR014821
DomainRyanodine_recept-rel

RYR1 RYR2

9.29e-0461492IPR015925
Domain-

RYR1 RYR2

9.29e-04614921.25.10.30
DomainRYDR_ITPR

RYR1 RYR2

9.29e-0461492PF01365
DomainPTEN_C2

GAK DNAJC6

1.72e-0381492PF10409
DomainPTEN_C2

GAK DNAJC6

1.72e-0381492SM01326
DomainC2_TENSIN

GAK DNAJC6

1.72e-0381492PS51182
DomainTensin_lipid_phosphatase_dom

GAK DNAJC6

1.72e-0381492IPR029023
DomainTensin_C2-dom

GAK DNAJC6

1.72e-0381492IPR014020
Pubmed

A novel gene family NBPF: intricate structure generated by gene duplications during primate evolution.

NBPF20 NBPF19 NBPF15 NBPF9 NBPF10 NBPF14

4.95e-1021163616079250
Pubmed

TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.

KCNMB2 TRAPPC11 AAMP MXRA5 TTC28 ZNFX1 TRIP11 RYR1 RYR2 KLHL3 USP8 OSBP NBPF15 RNF2 USP47

3.75e-076381631531182584
Pubmed

iNOS is not responsible for RyR1 S-nitrosylation in mdx mice with truncated dystrophin.

RYR1 DMD NOS1

4.03e-074163332693782
Pubmed

Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes?

TTC28 CEP164 NBPF9 NBPF10 NBPF14 SDK1 ELL UEVLD

1.51e-06170163823314748
Pubmed

Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability.

DSG2 INSR LBR TRIP11 PTK7 TMEM230 LNPEP SLC20A1 ABCD3 PEAK1 MARK2 BCL2L13

2.33e-064671631230194290
Pubmed

Cloning, sequencing and expression of the rearranged MOPC 315 VH gene segment.

IGHV4-61 IGHV4-34 IGHV4-31

3.49e-06716332497341
Pubmed

Model-building studies of antigen-binding sites: the hapten-binding site of mopc-315.

IGHV4-61 IGHV4-34 IGHV4-31

3.49e-0671633268248
Pubmed

Amino acid sequence of the precursor region of MOPC-315 mouse immunoglobulin heavy chain.

IGHV4-61 IGHV4-34 IGHV4-31

3.49e-0671633414225
Pubmed

The idiotypic network and the internal image: possible regulation of a germ-line network by paucigene encoded Ab2 (anti-idiotypic) antibodies in the GAT system.

IGHV4-61 IGHV4-34 IGHV4-31

3.49e-06716333937730
Pubmed

The structure of the expressible VH gene from a hybridoma producing monoclonal antibodies against porcine transferrin.

IGHV4-61 IGHV4-34 IGHV4-31

3.49e-06716332587273
Pubmed

Amino-acid sequence of the variable region of the heavy (alpha) chain of a mouse myeloma protein with anti-hapten activity.

IGHV4-61 IGHV4-34 IGHV4-31

3.49e-06716334524622
Pubmed

A new germline VH36-60 gene is used in the neonatal primary and adult memory response to (T,G)-A--L.

IGHV4-61 IGHV4-34 IGHV4-31

3.49e-06716331683681
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

KRT1 TTC28 DSG2 INSR LBR TRIP12 TRIP11 RYR2 BLM RIF1 ABCD3 PEAK1 DEPDC7 SDK1 DNMT1

4.25e-067771631535844135
Pubmed

Structure and function of immunoglobulin genes and precursors.

IGHV4-61 IGHV4-34 IGHV4-31

1.18e-05101633428562
Pubmed

Evolutionary history and genome organization of DUF1220 protein domains.

NBPF15 NBPF9 NBPF14

1.18e-0510163322973535
Pubmed

AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis.

RYR1 RYR2 DMD

1.18e-0510163318434328
Pubmed

Arrhythmogenic Right Ventricular Cardiomyopathy Overview

DSG2 DSP RYR2

1.18e-0510163320301310
Pubmed

A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.

GAK DSG2 TIPRL DNAJC6 PTK7 FANCD2 PTPN11 BABAM1 TRIM32 LNPEP ABCD3 TTC17 CDK1 MARK2 DMD USP47

1.51e-059741631628675297
Pubmed

Stretch-activated calcium channel protein TRPC1 is correlated with the different degrees of the dystrophic phenotype in mdx mice.

TRPC1 DMD

2.18e-052163221900691
Pubmed

Crosstalk between RyR2 oxidation and phosphorylation contributes to cardiac dysfunction in mice with Duchenne muscular dystrophy.

RYR2 DMD

2.18e-052163226555638
Pubmed

Evidence for multiple, developmentally regulated isoforms of Ptprq on hair cells of the inner ear.

PTPRZ1 PTPRQ

2.18e-052163220715155
Pubmed

A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice.

DMD NOS1

2.18e-052163211581289
Pubmed

The Bloom syndrome helicase is a substrate of the mitotic Cdc2 kinase.

BLM CDK1

2.18e-052163216880735
Pubmed

mdx muscle pathology is independent of nNOS perturbation.

DMD NOS1

2.18e-05216329536086
Pubmed

Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection.

DMD NOS1

2.18e-052163211717466
Pubmed

Case report of familial sudden cardiac death caused by a DSG2 p.F531C mutation as genetic background when carrying with heterozygous KCNE5 p.D92E/E93X mutation.

DSG2 KCNE5

2.18e-052163230129429
Pubmed

Auxilin depletion causes self-assembly of clathrin into membraneless cages in vivo.

GAK DNAJC6

2.18e-052163218489706
Pubmed

Ecto-5'-nucleotidase deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction.

NT5E INSR

2.18e-052163218391093
Pubmed

Skeletal and cardiac ryanodine receptors exhibit different responses to Ca2+ overload and luminal ca2+.

RYR1 RYR2

2.18e-052163217259277
Pubmed

The susceptibility of muscle cells to oxidative stress is independent of nitric oxide synthase expression.

DMD NOS1

2.18e-052163211268022
Pubmed

Ryanodine receptor oligomeric interaction: identification of a putative binding region.

RYR1 RYR2

2.18e-052163214722100
Pubmed

Molecular clues about the dystrophin-neuronal nitric oxide synthase interaction: a theoretical approach.

DMD NOS1

2.18e-052163224063785
Pubmed

Structural and functional interactions within ryanodine receptor.

RYR1 RYR2

2.18e-052163226009179
Pubmed

Structure and Function of the Human Ryanodine Receptors and Their Association with Myopathies-Present State, Challenges, and Perspectives.

RYR1 RYR2

2.18e-052163232899693
Pubmed

Muscular dystrophy in mdx mice despite lack of neuronal nitric oxide synthase.

DMD NOS1

2.18e-05216329681470
Pubmed

Nitric oxide generated by muscle corrects defects in hippocampal neurogenesis and neural differentiation caused by muscular dystrophy.

DMD NOS1

2.18e-052163219237426
Pubmed

Fatigue and muscle atrophy in a mouse model of myasthenia gravis is paralleled by loss of sarcolemmal nNOS.

DMD NOS1

2.18e-052163222952904
Pubmed

Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy.

DMD NOS1

2.18e-05216327545544
Pubmed

The Endosome-associated Deubiquitinating Enzyme USP8 Regulates BACE1 Enzyme Ubiquitination and Degradation.

BACE1 USP8

2.18e-052163227302062
Pubmed

An entirely specific type I A-kinase anchoring protein that can sequester two molecules of protein kinase A at mitochondria.

ADCYAP1R1 SPHKAP

2.18e-052163222084075
Pubmed

Variable phenotype of del45-55 Becker patients correlated with nNOSμ mislocalization and RYR1 hypernitrosylation.

RYR1 NOS1

2.18e-052163222589245
Pubmed

Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion.

RYR1 RYR2

2.18e-052163215033925
Pubmed

The decrease of expression of ryanodine receptor sub-type 2 is reversed by gentamycin sulphate in vascular myocytes from mdx mice.

RYR2 DMD

2.18e-052163219298530
Pubmed

Selection of a human anti-RhD monoclonal antibody for therapeutic use: impact of IgG glycosylation on activating and inhibitory Fc gamma R functions.

IGKC IGHV4-31

2.18e-052163216332457
Pubmed

Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy.

DMD NOS1

2.18e-05216328799168
Pubmed

A major role for mitotic CDC2 kinase inactivation in the establishment of the mitotic DNA damage checkpoint.

BLM CDK1

2.18e-052163215604258
Pubmed

Sarcolemmal targeting of nNOSμ improves contractile function of mdx muscle.

DMD NOS1

2.18e-052163226604149
Pubmed

Structural Basis of Neuronal Nitric-oxide Synthase Interaction with Dystrophin Repeats 16 and 17.

DMD NOS1

2.18e-052163226378238
Pubmed

BLM and the FANC proteins collaborate in a common pathway in response to stalled replication forks.

BLM FANCD2

2.18e-052163215257300
Pubmed

Insulin receptor kinase phosphorylates protein tyrosine phosphatase containing Src homology 2 regions and modulates its PTPase activity in vitro.

INSR PTPN11

2.18e-05216328135823
Pubmed

Cardiomyopathy in dystrophin-deficient hearts is prevented by expression of a neuronal nitric oxide synthase transgene in the myocardium.

DMD NOS1

2.18e-052163215917272
Pubmed

The protein tyrosine phosphatase RPTPζ/phosphacan is critical for perineuronal net structure.

PTPRZ1 TNR

2.18e-052163231822561
Pubmed

Population-prevalent desmosomal mutations predisposing to arrhythmogenic right ventricular cardiomyopathy.

DSG2 DSP

2.18e-052163221397041
Pubmed

GMAP210 and IFT88 are present in the spermatid golgi apparatus and participate in the development of the acrosome-acroplaxome complex, head-tail coupling apparatus and tail.

TRIP11 IFT88

2.18e-052163221337470
Pubmed

Automatic and unbiased segmentation and quantification of myofibers in skeletal muscle.

IFT88 DMD

2.18e-052163234083673
Pubmed

Evidence of oxidative stress in mdx mouse muscle: studies of the pre-necrotic state.

DMD NOS1

2.18e-05216329879685
Pubmed

MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway.

DMD NOS1

2.18e-052163220727829
Pubmed

Recent advances in understanding the ryanodine receptor calcium release channels and their role in calcium signalling.

RYR1 RYR2

2.18e-052163230542613
Pubmed

A role for nitric oxide in muscle repair: nitric oxide-mediated activation of muscle satellite cells.

DMD NOS1

2.18e-052163210793157
Pubmed

Ryanodine receptors are expressed and functionally active in mouse spermatogenic cells and their inhibition interferes with spermatogonial differentiation.

RYR1 RYR2

2.18e-052163215280431
Pubmed

Expression of the ryanodine receptor isoforms in immune cells.

RYR1 RYR2

2.18e-052163211673493
Pubmed

B-lymphocytes from malignant hyperthermia-susceptible patients have an increased sensitivity to skeletal muscle ryanodine receptor activators.

RYR1 RYR2

2.18e-052163211673462
Pubmed

Ceap/BLOS2 interacts with BRD7 and selectively inhibits its transcription-suppressing effect on cellular proliferation-associated genes.

BLOC1S2 BRD7

2.18e-052163218329849
Pubmed

FANCD2 limits BLM-dependent telomere instability in the alternative lengthening of telomeres pathway.

BLM FANCD2

2.18e-052163227427384
Pubmed

Nanoscale remodeling of ryanodine receptor cluster size underlies cerebral microvascular dysfunction in Duchenne muscular dystrophy.

RYR2 DMD

2.18e-052163230181262
Pubmed

Loss of positive allosteric interactions between neuronal nitric oxide synthase and phosphofructokinase contributes to defects in glycolysis and increased fatigability in muscular dystrophy.

DMD NOS1

2.18e-052163219542095
Pubmed

Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain.

RYR1 RYR2

2.18e-052163225370123
Pubmed

Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome.

GTF2IRD2B GTF2IRD2

2.18e-052163215388857
Pubmed

Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels.

RYR1 RYR2

2.18e-052163218618700
Pubmed

Optimization of Internally Deleted Dystrophin Constructs.

DMD NOS1

2.18e-052163227477497
Pubmed

Loss of nNOS inhibits compensatory muscle hypertrophy and exacerbates inflammation and eccentric contraction-induced damage in mdx mice.

DMD NOS1

2.18e-052163225214536
Pubmed

A common pathomechanism in GMAP-210- and LBR-related diseases.

LBR TRIP11

2.18e-052163230518689
Pubmed

Follow-up of a major linkage peak on chromosome 1 reveals suggestive QTLs associated with essential hypertension: GenNet study.

HSD17B7 TIPRL AXDND1 CD247 GPA33

2.64e-0574163519536175
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

RAB12 EHBP1 ATXN2L TTC28 DSG2 DSP LBR TIPRL PTPN11 ABCD3 CDK1 PEAK1 MARK2

3.19e-057081631339231216
Pubmed

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

EHBP1 DSG2 PDK1 INSR TRIP11 PTK7 USP8 PEAK1 MARK2 DMD

3.23e-054211631036976175
Pubmed

Defects in Stratum Corneum Desquamation Are the Predominant Effect of Impaired ABCA12 Function in a Novel Mouse Model of Harlequin Ichthyosis.

KRT1 DSG2 DSP

3.54e-0514163327551807
Pubmed

LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.

KRT1 DSP ZNFX1 TRIP12 MYO5C TTC17 DNMT1

4.98e-05202163733005030
Pubmed

Hypertonicity-responsive ubiquitin ligase RNF183 promotes Na, K-ATPase lysosomal degradation through ubiquitination of its β1 subunit.

EHBP1 GAK TTC28 DSG2 LBR TIPRL TRIP11 LNPEP ABCD3 CDK1

5.54e-054491631031732153
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

EHBP1 ATXN2L TTC28 DSG2 DSP LBR MAST2 TRIP12 TRIP11 USP8 AKAP11 PEAK1 MARK2 DNMT1

5.88e-058611631436931259
Pubmed

Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.

RARS1 SZT2 CHD9 RYR1 MYO5C ABCD3 CDK1

5.99e-05208163733230847
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

ATXN2L GAK RARS1 TTC28 DSG2 DSP TIPRL PTPN11 RNF2 PEAK1 DNMT1

6.08e-055491631138280479
Pubmed

Molecular mechanism of SLC5A8 inactivation in breast cancer.

SLC5A8 DNMT1

6.53e-053163223918800
Pubmed

Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study.

RYR1 RYR2

6.53e-053163218403125
Pubmed

The 8th and 9th tandem spectrin-like repeats of utrophin cooperatively form a functional unit to interact with polarity-regulating kinase PAR-1b.

MARK2 DMD

6.53e-053163219945424
Pubmed

A new look at cytoskeletal NOS-1 and β-dystroglycan changes in developing muscle and brain in control and mdx dystrophic mice.

DMD NOS1

6.53e-053163223940011
Pubmed

Neuronal nitric oxide synthase-rescue of dystrophin/utrophin double knockout mice does not require nNOS localization to the cell membrane.

DMD NOS1

6.53e-053163222003386
Pubmed

Novel risk genes for systemic lupus erythematosus predicted by random forest classification.

MANF CDK1

6.53e-053163228740209
Pubmed

The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues.

RYR1 RYR2

6.53e-05316327876312
Pubmed

Dendritic differentiation of cerebellar Purkinje cells is promoted by ryanodine receptors expressed by Purkinje and granule cells.

RYR1 RYR2

6.53e-053163224123915
Pubmed

Adapter function of protein-tyrosine phosphatase 1D in insulin receptor/insulin receptor substrate-1 interaction.

INSR PTPN11

6.53e-05316327493946
Pubmed

Defects in neuromuscular junction structure in dystrophic muscle are corrected by expression of a NOS transgene in dystrophin-deficient muscles, but not in muscles lacking alpha- and beta1-syntrophins.

DMD NOS1

6.53e-053163215238508
Pubmed

Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes.

RYR2 NOS1

6.53e-053163218077344
Pubmed

The beta secretase BACE1 regulates the expression of insulin receptor in the liver.

INSR BACE1

6.53e-053163229610518
Pubmed

Dopamine D1 receptor signaling system regulates ryanodine receptor expression in ethanol physical dependence.

RYR1 RYR2

6.53e-053163223278119
Pubmed

Glyphosate and AMPA Induce Alterations in Expression of Genes Involved in Chromatin Architecture in Human Peripheral Blood Mononuclear Cells (In Vitro).

TET3 DNMT1

6.53e-053163233803994
Pubmed

Bidirectional coupling between ryanodine receptors and Ca2+ release-activated Ca2+ (CRAC) channel machinery sustains store-operated Ca2+ entry in human T lymphocytes.

RYR1 RYR2

6.53e-053163222948152
Pubmed

Truncated dystrophin ameliorates the dystrophic phenotype of mdx mice by reducing sarcolipin-mediated SERCA inhibition.

DMD NOS1

6.53e-053163230236982
Pubmed

Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain.

RYR1 RYR2

6.53e-053163210788707
Pubmed

BioID-Screening Identifies PEAK1 and SHP2 as Components of the ALK Proximitome in Neuroblastoma Cells.

PTPN11 PEAK1

6.53e-053163234273398
Pubmed

Discovery of endoplasmic reticulum calcium stabilizers to rescue ER-stressed podocytes in nephrotic syndrome.

RYR2 MANF

6.53e-053163231235574
GeneFamilyNeuroblastoma breakpoint family

NBPF20 NBPF19 NBPF15 NBPF9 NBPF10 NBPF14

7.29e-09231216662
GeneFamilyFibronectin type III domain containing

ABI3BP INSR PTPRZ1 PTPRQ EGFLAM TNR SDK1

1.01e-041601217555
GeneFamilyRyanodine receptors|Protein phosphatase 1 regulatory subunits

RYR1 RYR2

1.33e-0431212287
GeneFamilyDNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing

GAK DNAJC18 DNAJC6 DNAJC5B

3.20e-04491214584
GeneFamilyDNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing

GAK DNAJC6

1.21e-0381212837
GeneFamilyZinc fingers CXXC-type

TET3 DNMT1

2.81e-03121212136
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCTD19 CECR2 RYR2 SORCS1 KIAA1549L PTPRZ1 SPHKAP PTPRQ SYCP1

7.70e-091601629c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCTD19 CECR2 RYR2 SORCS1 KIAA1549L PTPRZ1 SPHKAP PTPRQ SYCP1

7.70e-09160162925c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCellNon-neuronal-Non-dividing-OPC-OPC|World / Primary Cells by Cluster

NT5E RFTN2 BLM AFAP1L2 FIBIN PTPRZ1 PEAK1 TNR

4.75e-071891628ddf5be73912570c32c50f4ac2902da9b590526f8
ToppCellNon-neuronal-Non-dividing-OPC|World / Primary Cells by Cluster

NT5E RFTN2 BLM AFAP1L2 FIBIN PTPRZ1 PEAK1 TNR

4.75e-07189162813848a031ab896b4b24c8319e4745b9b17ff9cfd
ToppCellNon-neuronal-Non-dividing-OPC-OPC-30|World / Primary Cells by Cluster

NT5E RFTN2 BLM AFAP1L2 FIBIN PTPRZ1 PEAK1 TNR

4.75e-071891628313d165fad541ec6e8dd524b88856e2c93eeb681
ToppCell10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3|bone_marrow / Manually curated celltypes from each tissue

DSG2 RFTN2 PCDH20 SORCS1 AXDND1 TNR CPNE7

1.64e-06155162783430a64c2cb5ad29caa3dacba76c28dd204ac40
ToppCellEntopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Ntng1_(Entopeduncular_Nucleus_(Ent)_or_Zona_Incerta,_ventral_part_(ZIV)._State_signal?)|Entopeduncular / BrainAtlas - Mouse McCarroll V32

RGS22 TLR7 ARHGAP4 AXDND1 SLC5A8

1.87e-0656162520a2977f41d3ecbc4fbee7ecd6dfb4b7ce0e4bb7
ToppCellEntopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Ntng1_(Entopeduncular_Nucleus_(Ent)_or_Zona_Incerta,_ventral_part_(ZIV)._State_signal?)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32

RGS22 TLR7 ARHGAP4 AXDND1 SLC5A8

1.87e-06561625ad76712e6a99072f9c6dab6d746db54f754e14fd
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

KRT1 NPY2R PCDH20 SORCS1 PTPRZ1 CPNE7 NPAS1

2.29e-061631627ec9a20cfe0d69430f9c68cddd1ab0e4a3e4554b8
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

KCNMB2 KRT1 NPY2R PCDH20 SORCS1 CPNE7 NPAS1

2.69e-0616716271c1b4722c6c0eff85a9b32ca7b4e281caebf63b0
ToppCell390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)

KRT1 DCTN5 PDK4 OTUD1 ADGRL4 FIBIN IGKC

2.80e-061681627d7d19c93d1c3dd994e18e28d5f36ae7773ff5d7f
ToppCell356C-Endothelial_cells-Endothelial-B_(Artery)|356C / Donor, Lineage, Cell class and subclass (all cells)

ABI3BP OVOS2 ADGRL4 KLHL3 AFAP1L2 KIAA1549L NOS1

2.91e-061691627605cc2638271803cf1d972ab3fa8f13f89666376
ToppCell356C-Endothelial_cells-Endothelial-B_(Artery)-|356C / Donor, Lineage, Cell class and subclass (all cells)

ABI3BP OVOS2 ADGRL4 KLHL3 AFAP1L2 KIAA1549L NOS1

2.91e-061691627337be3bf485b54afad86e256cb0c4c1d0c2a9a2a
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

KCNMB2 KRT1 NPY2R PCDH20 PTPRZ1 CPNE7 NPAS1

3.15e-0617116275efd15300f865ebf651e0888265cbd717bc3b9d3
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

KRT1 NPY2R SORCS1 PTPRZ1 SDK1 CPNE7 NPAS1

3.27e-0617216277e1a7700a4c2b1d100da1d6e475e73498ebb605a
ToppCelldroplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CHD9 TRIP11 ESCO1 RYR2 LNPEP RAB7B DMD

3.81e-061761627749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells)

MXRA5 PCDHA6 RYR2 OLFML1 FIBIN PTPRQ DEPDC7

3.95e-0617716278220cc2fc0ee8764a67a3be51d75248be2453040
ToppCell356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells)

MXRA5 PCDHA6 RYR2 OLFML1 FIBIN PTPRQ DEPDC7

3.95e-0617716277617270f49cd6b7ba66db72d20560cee985012b2
ToppCellCalu_3-infected|Calu_3 / Cell line, Condition and Strain

DSP ETV7 CHD9 ZNFX1 TRIP12 RIF1 SAMD9L

4.92e-0618316278f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCellcellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

PDK1 IGKC MANF LY9 IGHV4-61 IGHV4-34 IGHV4-31

4.92e-0618316275ab4aa0304b832f98fff89b6c24ad5b7dd014c11
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

KCNMB2 NPY2R PDK4 KCNE5 FIBIN SPHKAP NOS1

5.28e-06185162774b787e225d83efcb84e79c23499febe1a106622
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

ABI3BP DOCK9 ADGRL4 AFAP1L2 KIAA1549L ST8SIA6 NOS1

5.28e-061851627a7ae76058b2082020cadec49d63b9f4e24d21734
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Tmem182|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

NPY2R NT5E SORCS1 TEX47 CPNE7 NPAS1

6.24e-061241626690595d710b57b7cff8029a3bb06a8dd7e3c03c1
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor

ABI3BP DOCK9 ADGRL4 AFAP1L2 KIAA1549L ST8SIA6 NOS1

6.29e-061901627f6c38d197fd9d69a4f97cb2e72cd4747984c1a86
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DSG2 DSP CHD9 TRIP11 ESCO1 SAMD9L AKAP11

6.51e-06191162760c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DSG2 DSP CHD9 TRIP11 ESCO1 SAMD9L AKAP11

6.51e-06191162709db184cb90fe282a14474d7217068c58092c6f8
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DSG2 DSP CHD9 TRIP11 ESCO1 SAMD9L AKAP11

6.51e-061911627973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCellBronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

PDK1 IGKC MANF LY9 IGHV4-61 IGHV4-34 IGHV4-31

7.46e-06195162713f4ee21568fd747608412d33559d10561dbb3c8
ToppCellControl_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type

DSP NT5E CECR2 MYO5C SPHKAP SLC22A3 ACSL5

7.97e-06197162744a59dfb889577b3160a5b13ada1276771a00241
ToppCellTracheal-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

RFTN2 DNAJC6 SORCS1 KLHL3 AFAP1L2 KIAA1549L EGFLAM

7.97e-0619716275c88a97e8e23a5cd61885acbe1ef339ae6a1e35a
ToppCellbackground-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells)

MXRA5 ABI3BP OLFML1 FIBIN EGFLAM DMD SDK1

8.24e-061981627bd11b0e9e80449aab979a02c1023e0638c431c7c
ToppCellFetal_brain-fetalBrain_Zhong_nature-GW26-OPC_related-OPC|GW26 / Sample Type, Dataset, Time_group, and Cell type.

RFTN2 PCDH20 FANCD2 AFAP1L2 FIBIN PTPRZ1 CDK1

8.79e-06200162702594c1edbc9f2cf831639cd83363abd2551cb94
ToppCellFetal_brain-fetalBrain_Zhong_nature-GW26-OPC_related|GW26 / Sample Type, Dataset, Time_group, and Cell type.

RFTN2 PCDH20 FANCD2 AFAP1L2 FIBIN PTPRZ1 CDK1

8.79e-06200162746521d83b917b0357601db8783c8da6b73730d60
ToppCellFrontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

KCNMB2 KRT1 NPY2R PCDH20 CPNE7 NPAS1

1.20e-051391626408bc31aa5e1c2b379f79198fe8b5411f8d7bd08
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

NPY2R SORCS1 PTPRZ1 NOS1 SDK1 CPNE7

1.53e-05145162678f5f4b96420c7f391e4d32a9ed151ed95fad90b
ToppCellLPS_only-Myeloid-Dendritic_cells-mDC|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

OTUD1 TLR7 KIAA1549L PYCARD IGKC RAB7B

1.65e-05147162626bd9d89e2e7b841cc18030bb7cebb642b987183
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

KRT1 NPY2R TEX47 PTPRZ1 CPNE7 NPAS1

1.72e-0514816265e738522d4ad35e08bc4ff8c41b7bea38ec6ef95
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

KRT1 NPY2R PCDH20 SDK1 CPNE7 NPAS1

1.72e-0514816269205b26e0d042b342cc643cda0f4f3f8bb392d00
ToppCellRV-16._Neuronal|World / Chamber and Cluster_Paper

DNAJC6 SORCS1 CACNA2D4 AFAP1L2 PTPRZ1 DEPDC7

1.78e-0514916263a2f8c4173dcf9e3f8d3b8ffddbc597098adf7a9
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

KCNMB2 KRT1 NPY2R PCDH20 CPNE7 NPAS1

2.07e-0515316269c6fce56300ba5053efda59a438d63a808c497c0
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

KRT1 NPY2R SORCS1 PTPRZ1 SDK1 CPNE7

2.23e-0515516263b8def9e8f66511736ea37f259511f7c8b7743af
ToppCell10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

KCNMB2 NT5E SORCS1 AFAP1L2 PTPRZ1 TNR

2.23e-05155162677fdae85d36efb776db977eb424b32487ef222e4
ToppCellFrontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

KCNMB2 KRT1 NPY2R PCDH20 CPNE7 NPAS1

2.57e-0515916267f29f9dcf25ffa1822b137c571e9ac16defc6292
ToppCelldroplet-Fat-SCAT-30m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SETMAR DHRS11 SORCS1 SPHKAP WNT16 NPAS1

2.66e-051601626fc76337ad766c859db390ef8b6fb9caeaace3a56
ToppCelldroplet-Fat-SCAT-30m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SETMAR DHRS11 SORCS1 SPHKAP WNT16 NPAS1

2.66e-05160162667ee7a314d7d4d3ea206e0158083f36f6dd7e80b
ToppCelldroplet-Fat-SCAT-30m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SETMAR DHRS11 SORCS1 SPHKAP WNT16 NPAS1

2.66e-051601626759749f708c3a2b36692d42499f19aff937e592f
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp4_Mab21l1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

NPY2R PCDH20 SDK1 CPNE7 NPAS1

2.67e-0596162578f19fee755061b4144b1beebb60f4e8bc4dbf0d
ToppCellBronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DHRS11 ADGRL4 KIAA1549L ST8SIA6 OLFML1 NOS1

3.06e-0516416263cd80e6275f0f9b5667912139d15ebf5e6b17f2f
ToppCell3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PDK1 BLM AXDND1 IGKC MANF IGHV4-61

3.28e-051661626a1009d25c5a500f470e8edb04097ac47d4d72f3c
ToppCell3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PDK1 BLM AXDND1 IGKC MANF IGHV4-61

3.28e-0516616265a6e3364d223829f66e8da7f3560d95fd8bb9b11
ToppCellwk_20-22-Hematologic-Myeloid-Mast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

KRT1 CCDC168 SAMSN1 ADPRH SAMD9L ST8SIA6

3.28e-051661626004ab6a1425d812c7ce572205875fd702d4a9659
ToppCell3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PDK1 BLM AXDND1 IGKC MANF IGHV4-61

3.28e-051661626e25bcbb5b3ba453a6e2572637f2521a32223a3ad
ToppCellFetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

NT5E DOCK9 DNAJC18 ADGRL4 ST8SIA6 NOS1

3.28e-051661626f7926ee266dcbf10df375cd921f1db5a2fa604f8
ToppCellICU-NoSEP-Lymphocyte-T_NK-MAIT|ICU-NoSEP / Disease, Lineage and Cell Type

TRGV5 DCAF5 AFAP1L2 USP51 SPATA9 CPNE7

3.28e-051661626d3fa2e42497201f1ca57f4f977fbaa0def950033
ToppCellLA-16._Neuronal|World / Chamber and Cluster_Paper

EHBP1 DNAJC6 SORCS1 AFAP1L2 PTPRZ1 DEPDC7

3.50e-0516816262fd1fd2a16ac1c5eb028f93cc3a2477c7747693e
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

KCNMB2 PCDH20 PTPRZ1 SDK1 CPNE7 NPAS1

3.50e-051681626f3879a8e11eaf866f37c52e67021be43f0b8784a
ToppCell(3)_MNP-(3)_DC_plasmacytoid|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4)

DSG2 KCNE5 PTK7 SLC20A1 IGKC LY9

3.50e-05168162613c160ea1a19b47d2e7e2dae818c8dcde4e3e377
ToppCell390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

DCTN5 PDK4 OTUD1 ADGRL4 FIBIN IGKC

3.62e-051691626d2def7229fe9d6b0c70cfed349ede491c8c137a0
ToppCellPND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NT5E LBR CD247 PYCARD LY9 DNMT1

3.62e-051691626b08567ecfa3f8d83e7990330fc1b27f0bb7e75a1
ToppCellLV-16._Neuronal|LV / Chamber and Cluster_Paper

EHBP1 DNAJC6 SORCS1 AFAP1L2 PTPRZ1 DEPDC7

3.62e-051691626a8fc8ab0f0757e939e213efb61c03cfe390bf7d2
ToppCellPND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CECR2 LBR FANCD2 IGKC CDK1 LY9

3.74e-051701626e08a6c5ac34c456da8c7318f104e06fca585be1f
ToppCellRV-03._Atrial_Cardiomyocyte|RV / Chamber and Cluster_Paper

PDK4 RYR2 AXDND1 SYCP1 DMD

4.11e-05105162549e16b11f16e83a7d17d162c14bce991201bcc2a
ToppCell356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells)

KCNMB2 MXRA5 ABI3BP RFTN2 RYR2 PTPRQ

4.69e-051771626cdfd2f0ee2f692271b1525e414b0f645cdadb1f6
ToppCell356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells)

KCNMB2 MXRA5 ABI3BP RFTN2 RYR2 PTPRQ

4.69e-051771626db222faaecbe5600da39277243c4e7e764eb63c9
ToppCelldroplet-Lung-30m-Epithelial-alveolar_epithelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

KCNMB2 DSG2 DSP CECR2 RYR2 MYO5C

4.84e-05178162676e71fff99cf64302e2e3c0d66dd8ba0ff13624e
ToppCelldroplet-Lung-30m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

KCNMB2 DSG2 DSP CECR2 RYR2 MYO5C

4.84e-05178162682f78ea1ea3ff3e2347cd8bc2f06e2a10e96f220
ToppCelldroplet-Lung-30m-Epithelial-alveolar_epithelial-type_II_pneumocyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

KCNMB2 DSG2 DSP CECR2 RYR2 MYO5C

4.84e-051781626523b286ebe0359c7f1902f28cbd71f452626fc0d
ToppCelldroplet-Lung-30m-Epithelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

KCNMB2 DSG2 DSP CECR2 RYR2 MYO5C

4.84e-0517816265442bc52b8e902da1383f44d97a9f95e471a8d4d
ToppCellCOVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

ABI3BP TTC28 DOCK9 INSR ADGRL4 KIAA1549L

4.99e-0517916261ce8d18f63e8dd2d3db41fbeca4601bd3b305fba
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PDK1 IGKC LY9 IGHV4-61 IGHV4-34 IGHV4-30-2

5.15e-051801626e3877f6ef5f54ff689058b4c996ab1851822f871
ToppCell3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DSP NBPF19 SAMD9L NBPF9 NBPF10 GPA33

5.15e-051801626b234668bf181522807470e396792e1b54890b719
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PDK1 IGKC MANF IGHV4-61 IGHV4-34 IGHV4-30-2

5.31e-051811626e47664a264a2c37390d1668ce04eef2e0172f4cb
ToppCelldroplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CHD9 TRIP11 SAMD9L CD247 SLC22A3 PEAK1

5.47e-051821626e78ba2c5cae480c16a596ce7c3bf2d480becacf4
ToppCelldroplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CECR2 CHD9 TRIP11 USP8 SAMD9L RAB7B

5.47e-051821626f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCelldroplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CHD9 TRIP11 SAMD9L CD247 SLC22A3 PEAK1

5.47e-0518216261710eab3037a87609d21838be2d2d29c3bc36651
ToppCellControl-Epithelial_alveolar-AT_2-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DSP NT5E CECR2 MYO5C SLC22A3 ACSL5

5.47e-051821626e97681a4102f3095d5d9e90ad70f1dc46e90983a
ToppCellPCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

SORCS1 AFAP1L2 PTPRZ1 WNT16 RAB7B EGFLAM

5.47e-051821626f7f9be9c7ef8da9864d6aefe20043b26e1bb8697
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_KLHL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

KCNMB2 BLM ST8SIA6 SPHKAP SLC5A8 NPAS1

5.64e-051831626439b1d1373b7cc73d65f3b59037a6def7cf8f4ba
ToppCell3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PDK1 IGKC MANF IGHV4-61 IGHV4-34 IGHV4-30-2

5.64e-051831626cf5c98f451a568308c52da5c926543dd4836c6b2
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RGS22 RYR2 SORCS1 PTPRQ DMD SDK1

5.81e-0518416262cbed6462fea2622871bb7e49b0df3d984239281
ToppCellControl-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DSP CECR2 MYO5C SPHKAP SLC22A3 ACSL5

5.81e-05184162651e129b3fcc2df083eda05a3afe3717218b1e52b
ToppCellPCW_10-12-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

DOCK9 ADGRL4 ARHGAP4 ST8SIA6 EGFLAM NOS1

5.81e-051841626a809b0fa52df8a159f60f87eefcef61220af5e34
ToppCelldroplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CHD9 TRIP11 USP8 SAMD9L LNPEP RAB7B

5.81e-0518416261154a5ad7b8512272b7476f949ddac350910bfb7
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RGS22 RYR2 SORCS1 PTPRQ DMD SDK1

5.81e-0518416262b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RGS22 RYR2 SORCS1 PTPRQ DMD SDK1

5.81e-051841626ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellMid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CECR2 RFTN2 BLM AFAP1L2 PTPRZ1 TNR

5.99e-0518516262e1766f1a972fecd670daaaf7eb2d3a404f121e7
ToppCellMid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CECR2 RFTN2 BLM AFAP1L2 PTPRZ1 TNR

5.99e-0518516267aaa8335b40927e3e8fdcede807cd521fc213a0d
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PDK1 IGKC MANF IGHV4-61 IGHV4-34 IGHV4-30-2

5.99e-0518516261704a12153a9b107bf03ecccd1a036cf61334d7a
ToppCell3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PDK1 IGKC MANF IGHV4-61 IGHV4-34 IGHV4-30-2

5.99e-0518516266ec009e48e50471c28e914c402f500e56a88f8f2
ToppCell3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PDK1 IGKC MANF IGHV4-61 IGHV4-34 IGHV4-30-2

5.99e-051851626f49ad6401b2abd089e30eba245b11b5031ea2318
ToppCelldroplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CECR2 CHD9 TRIP11 USP8 SAMD9L RAB7B

5.99e-0518516267adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PDK1 IGKC MANF IGHV4-61 IGHV4-34 IGHV4-30-2

5.99e-05185162608bc817908076734d66f2805cb954141f2cc5a18
ToppCellhealthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass

DENND2C IGKC MANF IGHV4-61 IGHV4-34 IGHV4-31

6.17e-051861626e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67
ToppCelldroplet-Thymus-nan-18m-Myeloid-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DSG2 DSP PDK4 CFAP43 MYO5C RAB7B

6.36e-051871626ed69e7cbd6fb59363b0e26f24887fc49405397ce
ToppCellControl-Endothelial_cells-Arterial_endothelial_cells|Control / group, cell type (main and fine annotations)

ABI3BP TTC28 DOCK9 ADGRL4 ST8SIA6 NOS1

6.36e-05187162681affaab3fe3e1daea45ada6445e906ddd33950e
ToppCellfacs-Brain_Non-Myeloid-Striatum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT1 PCDH20 ADCYAP1R1 PTK7 PTPRZ1 TNR

6.55e-0518816267471c194276161422326647f09022e94f3d1640c
ToppCellfacs-Brain_Non-Myeloid-Striatum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT1 PCDH20 ADCYAP1R1 PTK7 PTPRZ1 TNR

6.55e-051881626053c251d3ddbeb866f34565aefca4535517b4387
ToppCellkidney_cells-Adult_normal_reference-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

KCTD19 FANCD2 CD247 CDK1 GPA33 DNMT1

6.94e-05190162689095d3e023269d89c82e3a73550f869e3f34201
ToppCellkidney_cells-Adult_normal_reference-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

KCTD19 FANCD2 CD247 CDK1 GPA33 DNMT1

6.94e-051901626b65383e256b04122500b742caeed0b807793851e
ToppCellnucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

ABI3BP TTC28 DOCK9 ADGRL4 ST8SIA6 NOS1

7.15e-05191162650601ef0a5a8f2c2120922989e08e85bf2d9b4ab
Diseasevenous thromboembolism, fibrinogen measurement

ATXN2L DCHS2 CHD9 SNX13 TTC17

2.54e-05671525EFO_0004286, EFO_0004623
DiseaseParkinson's disease 19A (implicated_via_orthology)

GAK DNAJC6

2.64e-0521522DOID:0060891 (implicated_via_orthology)
Diseaseidiopathic scoliosis (implicated_via_orthology)

KATNB1 PTK7 PTPN11

7.14e-05161523DOID:0060250 (implicated_via_orthology)
Diseasecongenital myopathy 1A (implicated_via_orthology)

RYR1 RYR2

7.88e-0531522DOID:3529 (implicated_via_orthology)
Diseasemalignant hyperthermia (implicated_via_orthology)

RYR1 RYR2

7.88e-0531522DOID:8545 (implicated_via_orthology)
DiseaseStriate palmoplantar keratoderma

KRT1 DSP

7.88e-0531522C4707237
Diseasehypertrophic cardiomyopathy (is_marker_for)

DSP ADGRL4 DNMT1

8.64e-05171523DOID:11984 (is_marker_for)
Diseasecongenital left-sided heart lesions

KCNMB2 CFAP43 ADCYAP1R1 AFAP1L2

1.10e-04481524EFO_0005938
DiseaseIschemic stroke, fibrinogen measurement

ATXN2L CHD9 SNX13 TTC17

1.88e-04551524EFO_0004623, HP_0002140
DiseaseDuchenne muscular dystrophy (is_marker_for)

DMD NOS1

2.61e-0451522DOID:11723 (is_marker_for)
DiseaseCarcinoma, Granular Cell

PTPN11 PYCARD SYCP1 MUC2 DNMT1

3.44e-041161525C0205644
DiseaseAdenocarcinoma, Tubular

PTPN11 PYCARD SYCP1 MUC2 DNMT1

3.44e-041161525C0205645
DiseaseAdenocarcinoma, Oxyphilic

PTPN11 PYCARD SYCP1 MUC2 DNMT1

3.44e-041161525C0205642
DiseaseCarcinoma, Cribriform

PTPN11 PYCARD SYCP1 MUC2 DNMT1

3.44e-041161525C0205643
DiseaseAdenocarcinoma, Basal Cell

PTPN11 PYCARD SYCP1 MUC2 DNMT1

3.44e-041161525C0205641
DiseaseAdenocarcinoma

PTPN11 PYCARD SYCP1 MUC2 DNMT1

3.44e-041161525C0001418
DiseaseSquamous cell carcinoma

KRT1 BLM PTPN11 AFAP1L2 PYCARD

4.67e-041241525C0007137
Diseasedrug use measurement, quality of life during menstruation measurement

SYCP1 SDK1

5.44e-0471522EFO_0007010, EFO_0009366
DiseaseArrhythmogenic right ventricular cardiomyopathy

DSG2 DSP

5.44e-0471522cv:C0349788
DiseaseCardiomyopathies

DSG2 DSP RYR2 PTPN11 DMD

5.80e-041301525C0878544
DiseaseParkinson Disease

GAK INSR TMEM230 NOS1

9.91e-04851524C0030567
Diseasearrhythmogenic right ventricular cardiomyopathy (is_implicated_in)

DSP RYR2

1.15e-03101522DOID:0050431 (is_implicated_in)
Diseasefibrinogen measurement, coronary artery disease

DCHS2 CHD9 SNX13 TTC17 ELL

1.24e-031541525EFO_0001645, EFO_0004623
Diseasevery long-chain saturated fatty acid measurement

SAMSN1 ADCYAP1R1 RAB7B

1.52e-03441523EFO_0006796
Diseasefibrinogen measurement, tissue plasminogen activator measurement

ATXN2L CHD9 SNX13

1.62e-03451523EFO_0004623, EFO_0004791
Diseasecortisol measurement, response to corticosteroid, response to synacthen

NOS1 BCL2L13

1.98e-03131522EFO_0005843, EFO_0009175, GO_0031960
DiseaseHepatic fibrosis

KIAA1549L TNR SDK1

2.08e-03491523HP_0001395
DiseaseAutosomal recessive limb-girdle muscular dystrophy

TRAPPC11 TRIM32

2.30e-03141522cv:C2931907
Diseaselymphocyte percentage of leukocytes

TTC28 CECR2 PCDHA6 ADGRL4 GTF2IRD2B LNPEP GTF2IRD2 LY9 BCL2L13 ELL

2.43e-0366515210EFO_0007993
Diseasefibrinogen measurement

DCHS2 CHD9 SNX13 TTC17

2.48e-031091524EFO_0004623
Diseasehepatic encephalopathy (biomarker_via_orthology)

INSR NOS1

2.65e-03151522DOID:13413 (biomarker_via_orthology)
Diseaseleukemia

BLM FANCD2 PTPN11

2.89e-03551523C0023418
DiseasePolydactyly

LBR CEP164 IFT88 TRIM32

3.20e-031171524C0152427
Diseasefibrinogen measurement, factor VII measurement

ATXN2L SNX13 TTC17

3.36e-03581523EFO_0004619, EFO_0004623
Diseaseproprotein convertase subtilisin/kexin type 7 measurement

BACE1 CEP164

3.41e-03171522EFO_0008270
Diseasepre-malignant neoplasm (biomarker_via_orthology)

INSR MUC2

3.41e-03171522DOID:0060071 (biomarker_via_orthology)
Diseaseperinatal necrotizing enterocolitis (biomarker_via_orthology)

TLR7 MUC2

3.41e-03171522DOID:8677 (biomarker_via_orthology)
DiseaseMYELODYSPLASTIC SYNDROME

BLM FANCD2 PTPN11

5.04e-03671523C3463824

Protein segments in the cluster

PeptideGeneStartEntry
SALLQFGVTYLEDYS

BCL2L13

176

Q9BXK5
YLTGELTATSEDYKL

BLOC1S2

51

Q6QNY1
TYIEILAESSSLLGY

ADGRL4

161

Q9HBW9
DLTDKLVSFYLETYG

PYCARD

51

Q9ULZ3
AVSEKALLSSYLVAY

FAM200B

141

P0CF97
SSSYTLKNDYETLSL

FAM200B

566

P0CF97
YNYDKSIVDSGTTNL

BACE1

281

P56817
KGNILLDYTLLSFSY

CFAP43

106

Q8NDM7
LYSYDTGSKDFLSIN

EGFLAM

651

Q63HQ2
TSTSETPDYLLKYAA

ELL

501

P55199
SGYEAKVYSATNVEL

ANKRD13D

261

Q6ZTN6
DLDSRVLYYSATKNG

DNMT1

916

P26358
YLDGTLAIYDLATQT

AAMP

336

Q13685
ISKDDSDLIYSTYGE

BRD7

421

Q9NPI1
DIAEKYLSASEYGSS

AFAP1L2

296

Q8N4X5
SKYATGIRYTLDTFL

AKAP11

146

Q9UKA4
EQQSGLYYLSTTVKE

DMD

991

P11532
SNYLDRGILKAYSDS

DEPDC7

246

Q96QD5
LTDISKRSIYDKYGS

DNAJC5B

71

Q9UF47
TKRQSSLSASEYLYG

CECR2

1326

Q9BXF3
EENYGVKTTYDSSLS

ATXN2L

261

Q8WWM7
SITSAYYRSAKGIIL

RAB12

106

Q6IQ22
KTFYEEYQTTLGASI

RAB7B

31

Q96AH8
ELTTFYYKQGLSLID

RFTN2

286

Q52LD8
DSTSQLYTVKYKDGT

LBR

31

Q14739
SRSVSYSILGKYLQE

KCTD19

911

Q17RG1
EKSIYGTVYSLSSLL

NPY2R

211

P49146
EGKFLYISETVSIYL

NPAS1

156

Q99742
SILTYKLSSSEYFGL

PCDHA6

166

Q9UN73
YGTDAVIYIKALSTD

PDK1

381

Q15118
YGTDAIIYLKALSSE

PDK4

356

Q16654
FYLNKDTGEIYTTSV

DSG2

211

Q14126
ALLASDTYVLDYLKS

OVOS1

791

Q6IE37
DTYVLDYLKSTEQLT

OVOS1

796

Q6IE37
DKDLGTNAQITYSYS

PCDH20

346

Q8N6Y1
LYRAVSKTVYGDQSL

OTUD1

321

Q5VV17
VDKVTYGSFDYTSLL

OGFOD3

231

Q6PK18
ATYSSDKGLISRIYN

nan

1041

O00370
VYVNLTSSGEKLLLY

KCNMB2

116

Q9Y691
VSLKNISTDTSGYYI

GPA33

196

Q99795
LKLSSVTAADTAVYY

IGHV4-31

101

P0DP07
LKLSSVTAADTAVYY

IGHV4-30-2

101

A0A087WSY4
VTSAKGDDAYLYILL

KCNE5

51

Q9UJ90
TVSTEDGLLKAKYLY

FAM185A

231

Q8N0U4
YESYVQTGCTSLKLI

KATNB1

571

Q9BVA0
LKLSSVTAADTAVYY

IGHV4-30-4

101

P0DP06
LKLSSVTAADTAVYY

IGHV4-61

101

A0A0C4DH41
SLYQSKYEELQITAG

KRT1

371

P04264
LGYLGYSILTEQESQ

RHOT1

381

Q8IXI2
SDAYTKVYSRAGLTL

MUC2

131

Q02817
SSISYELKGLDIESY

PEAK1

1201

Q9H792
YISYSNNKDGETSLV

DCAF5

671

Q96JK2
EGRNYSKYQSVSLLD

LNPEP

661

Q9UIQ6
LSQLSAELVGFYLTY

KIAA1549L

1021

Q6ZVL6
YGAKSDIIYVQTDAT

INSR

606

P06213
EYTNIKYSLADQTSG

PTPN11

541

Q06124
SLQGLTISYASEKYE

PTPRZ1

1256

P23471
YSSVNTPKLITDSLY

OR4C13

71

Q8NGP0
LLASDTYVLDYLKST

OVOS2

966

Q6IE36
VLSNGLLSYYRSKAE

OSBP

111

P22059
YYIGATDDAATKIIN

MANF

76

P55145
TYTSEYKSAVGNLAL

OLFML1

76

Q6UWY5
LSVKALYTVGYSTSL

ADCYAP1R1

151

P41586
TSTYQLKDTELIYGA

NOS1

396

P29475
TILYATETGKSQAYA

NOS1

761

P29475
TEKGFSDTYTAQLYI

PTPRQ

1171

Q9UMZ3
QGNLESQLTSESYYK

THAP12

561

O43422
TKAILDYELTSSYSL

DCHS2

2301

Q6V1P9
ANYAKGDLDISYITS

GAK

401

O14976
AGLTDDEKTYYSLIT

ENOPH1

236

Q9UHY7
YTTKLLDSPGAATEY

CHD9

2296

Q3L8U1
SCTEALYNIGLTYEK

IFT88

516

Q13099
LDTKGTSYKYEVALA

BABAM1

271

Q9NWV8
YLTGDKTDSEATNIY

BLM

736

P54132
LVDLQYSLAKSYAST

DOCK9

1596

Q9BZ29
SSGDVLYELLQYIKT

ETV7

101

Q9Y603
LYQGLSTATKDTYDA

CD247

141

P20963
GDLYNTVTKYSGSLL

CACNA2D4

86

Q7Z3S7
DISFLYDVTYAKGQT

AXDND1

126

Q5T1B0
FLKSDIYLEYTRTGS

AXIN1

201

O15169
AEESTGKASQYYILL

CPNE7

501

Q9UBL6
YELQLASYTSGLETL

DSP

961

P15924
LKLASTGTSEYAAYD

INTS14

486

Q96SY0
VTSYTKGDLDFTYVT

DNAJC6

56

O75061
LSYKQVSDRAEYLGS

ACSL5

106

Q9ULC5
EPYSSSKYATDLLSV

HSD17B7

191

P56937
LDSSYGITKSLENIY

DENND2C

181

Q68D51
LLYNKSEYIETASGN

DCTN5

6

Q9BTE1
TSKLGYSYSRDLDLA

EHBP1

761

Q8NDI1
TLYSVLSQGYEKLDT

LY9

506

Q9HBG7
YSLSSTLTLSKADYE

IGKC

66

P01834
ATYLLLGYKSSELEG

MARK2

356

Q7KZI7
DKSRSGLITSQYFYE

MAST2

371

Q6P0Q8
LFYKSTLGYTISRET

DNAJC18

256

Q9H819
VDGQTLSKLIDYIYT

KLHL3

96

Q9UH77
TGLASVEAYSYKTNE

KLHL3

406

Q9UH77
LRSNFIYGSYLSKEE

ESCO1

791

Q5FWF5
DNVIYIYSVSSDGAK

EML3

701

Q32P44
KYTLSYLNDITGDSN

CCDC168

4611

Q8NDH2
FTTLLYELDSQYGSL

GTF2IRD2

691

Q86UP8
FTTLLYELDSQYGSL

GTF2IRD2B

691

Q6EKJ0
ISKSISYDLDGEESY

FIBIN

101

Q8TAL6
YSATKYAVTALTEGL

DHRS11

166

Q6UWP2
YTLSLDKLRQGVTYE

SDK1

1961

Q7Z5N4
YLVYDTGDVSSKVAT

SLC20A1

546

Q8WUM9
GKYLSSNYSEITVTD

SLC22A3

316

O75751
YRTLCSIYSLGTTKN

RYR1

3166

P21817
SLYALGTSKSIYVER

RYR2

3136

Q92736
ASEKQYTIYIATASG

RNF2

286

Q99496
LDQSIISFGSLLYKY

FANCD2

446

Q9BXW9
LKLSSVTAADTAVYY

IGHV4-34

106

P06331
GYTYDTSDLAAIKQR

RARS1

381

P54136
SFVLVEGYSYVKLLS

SZT2

626

Q5T011
AAVGIYEQYLSEKAS

SNX13

441

Q9Y5W8
LLLDYYAGKNASSIL

SPHKAP

1146

Q2M3C7
LIGVTDSYDNSLKVY

TRIM32

441

Q13049
ESSSDTLYKVLLDYI

TEX47

101

Q8TBZ9
SSAVYSLEEQYLGLA

NBPF9

901

P0DPF3
SSAVYSLEEQYLGLA

NBPF10

976

Q6P3W6
SSAVYSLEEQYLGLA

NBPF10

2196

Q6P3W6
SSAVYSLEEQYLGLA

NBPF10

3416

Q6P3W6
SSAVYSLEEQYLGLA

NBPF14

711

Q5TI25
SSAVYSLEEQYLGLA

NBPF15

461

Q8N660
SSAVYSLEEQYLGLA

NBPF19

461

A0A087WUL8
SSAVYSLEEQYLGLA

NBPF19

1681

A0A087WUL8
SSAVYSLEEQYLGLA

NBPF19

2901

A0A087WUL8
SSAVYSLEEQYLGLA

NBPF20

361

P0DPF2
SSAVYSLEEQYLGLA

NBPF20

1581

P0DPF2
SSAVYSLEEQYLGLA

NBPF20

2801

P0DPF2
SSAVYSLEEQYLGLA

NBPF20

4021

P0DPF2
LVSNGDYYLSAEILS

RGS22

461

Q8NE09
LQFSYTGTYDSELLE

RIF1

896

Q5UIP0
NSYISDTLGQVYKSE

SAMD9L

1116

Q8IVG5
QEYTSTLLLNGYETL

SAMSN1

256

Q9NSI8
DYSGRYLNLTVSEDK

SETMAR

261

Q53H47
NTGTSFKVYYTLEES

ST8SIA6

276

P61647
LYYDVSNSKDVLESG

TRGV5

66

A0A0B4J1U4
GITSTYEYLELRFNK

SLC5A8

111

Q8N695
KYLEQQYGISSSDAI

SLCO1A2

341

P46721
KTALTSIIYASYAAL

SPATA9

141

Q9BWV2
IKTDYTLSIANRLYG

SERPINB12

106

Q96P63
TETFYLTKLQEYLSG

ARHGAP4

436

P98171
LKSTHSELLEDYYQS

ABCD3

346

P28288
LDNYSTQELGKTIVY

NT5E

331

P21589
VKERDQFYTSLSYSG

ADPRH

251

P54922
DSSLVKSYLYQILQG

CDK1

101

P06493
TSAYTKGLLGSIYED

CEP164

191

Q9UPV0
FTIGLTQLYDKGYTS

TRPC1

551

P48995
SYKTGIYSVELINDS

UBE2Q2

221

Q8WVN8
TKATIEDLLYSEGYL

USP51

686

Q70EK9
DYITYSLELLGRAST

TRAPPC11

511

Q7Z392
TSETGSYDGVLYENK

MIOS

596

Q9NXC5
LLSALSYLGFETYQV

RMDN1

56

Q96DB5
LENSEGLSRVYSKLY

SYCP1

96

Q15431
TYTTDYKGTLLGESL

TIPRL

111

O75663
YVLTYKSTDGSRKEL

TNR

1071

Q92752
YSSILNKSETGYVGL

USP47

176

Q96K76
YELSSGTKETAFIYA

WNT16

111

Q9UBV4
GDTLYQELTDTLRKY

TET3

936

O43151
LYDGTYITLESKDIS

TTC17

126

Q96AE7
RSFSGLTYLKSLYLD

TLR7

121

Q9NYK1
TNAGYDYLALKTLSS

RIOK2

76

Q9BVS4
NIISGKYDSTAIYLD

ZNFX1

356

Q9P2E3
LLKGSSSNEYLYERF

TTC28

1436

Q96AY4
SKLQVDYTGLIQSYE

TRIP11

1261

Q15643
VSALAKGYYDINSEV

UEVLD

411

Q8IX04
VYPTSLTKNYLEDSL

UGT2B15

76

P54855
NSLRYKIYLSDSLTG

ABI3BP

976

Q7Z7G0
LTKLYDYNLGSITES

SORCS1

191

Q8WY21
LISSDEGATYQKYRL

SORCS1

256

Q8WY21
KTLFGVLYEVYSSSA

TRIP12

836

Q14669
VSALGLSKDVYNSEY

PTK7

946

Q13308
KVKYSRLSSTDDGYI

TMEM230

16

Q96A57
VKSSAAYILFYTSLG

USP8

1096

P40818
YSNLVSLDLESKTYE

ZNF283

106

Q8N7M2
SSEKYQIYQDGTLLI

MXRA5

2391

Q9NR99
FAESKLIYTYSGIIL

MYO5C

91

Q9NQX4